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Conclusions. There is no statistical correlation between the waiting time until surgery >5 weeks and a better pathological response.
It would be necessary to design speciﬁc studies to prove the stated hypothesis. The local survival data is related to the sample
characteristics (older patients, comorbidities).
http://dx.doi.org/10.1016/j.rpor.2013.03.221
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Introduction. We describe our series of patients treated with SBRT liver since 2010. Target Analyze dosimetric aspects, treatment
response and acute toxicity.
Materials and methods. CT-simulation c/c IV (slice thickness) with body stereotactic body frame (ELEKTA) with mattress individu-
alized and diaphragmatic compression. Post-immobilization ﬂuoroscopy to determine the three-dimensional displacement and
decide PTV margins. Use liver-window/level for Identify the lesion. Image Fusion (PET-CT or MRI). SYNERGY multi-energy linear
accelerator. Isocenter stereotactic localization (Dynatrac system). Robotic table (6 degrees of freedom-Hexapod). Image-guided RT
(IGRT) cone beam. We included 11 treatments in 7 patients (p), (3 of them with several locations: 2 p treated LOES simultaneous
2–3 and 1 p treated twice). Histology: 1 hepatocarcinoma, the rest metastases: adenocarcinomas of colon, pancreas, rectum,
small cell lung, bladder urothelial. 6 males. Average age: 64 years (50–72).
Results. Average GTV volume: 18.5 cm3 (1.1–68.2), average PTV volume: 44 cm3 (7.2–150) (largest PTV: 72 year old woman treated
6 months ago, hepatic EE (RMI), currently receiving chemotherapy because of lung PE). Radiotherapy techniques: 2 IMRT-SS
(beams/segments: 11/54, 12/24), 1 VMAT-SA and 8 RT-3D (11–29 beams). Schemes as characteristics of the case, the most used:
8×7.5Gy (other: 8×7, 7×8, 5×12 and 6×9). Well tolerated without acute toxicity registration. Mean follow-up: 14 months (3–24).
Local progression free interval range: 14 months (3–24). Median overall survival: 33 months (12–43). Status: Only 1 patient died
of distant disease, 2 p current ongoing SBRT (other locations).
Conclusions. The SBRT achieves ablation of hepatic lesions and constitute a valid option compared to surgical resection of the
same, with a great tolerance. Although optimal schemes fraction dose have not been established, our scheme is consistent with
published hypofractionated.
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Purpose. To evaluate the tumor volume reduction rate (TVRR) measured by magnetic resonance volumetry and to correlate with
the pathologic tumor response after preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer.
Materials and methods.Ten consecutive patientswith locally advanced rectal cancer (TNMStage III–IV) hadundergonepreoperative
CRT and radical surgery. The tumor volume was measured using three-dimensional magnetic resonance volumetry before and
after CRT, before surgery. We analyzed the correlation between the TVRR and the pathologic tumor response in terms of tumor
regression grade (TGR) proposed by Rye et al.
Results. The mean tumor volume was 42 cm3 (max 76, min 14) before and 12 cm3 (max 36 and min 0 cm3) after CRT. The mean
TVRR was 70.31% (max 100%, min, 29%). The TGR was: 5 patients with TGR 0 and 1, and 5 patients with TGR 2 and 3. TVRR after
CRT was different between patients with poor TGR (2 and 3) and those with good TGR (0 and 1). The patients with good regression
(TGR 0 and 1) had TVRR>75%, and those with poor regression (TGR 2 and 3) had TVRR<75%.
Conclusion. The TVRR measured using three-dimensional magnetic resonance volumetry correlated well with the pathologic
tumor response in terms of TGR after preoperative CRT for locally advanced rectal cancer. This conclusion is consistent with the
results reported in the literature.
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